Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Abstract Background Growing evidence has demonstrated that DNA methylation (DNAm) plays an important role in Alzheimer’s disease (AD) and that DNAm differences can be detected in the blood of AD subjects. Most studies have correlated blood DNAm with the clinical diagnosis of AD in living individuals...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Wei Zhang, Juan I. Young, Lissette Gomez, Michael A. Schmidt, David Lukacsovich, Achintya Varma, X. Steven Chen, Eden R. Martin, Lily Wang
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2023-04-01
Ráidu:	Alzheimer’s Research & Therapy
Fáttát:	DNA methylation CSF biomarkers Alzheimer’s disease
Liŋkkat:	https://doi.org/10.1186/s13195-023-01216-7
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!